Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001790340-25-000024
Filing Date
2025-02-07
Accepted
2025-02-07 16:10:23
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738962616.html 4  
1 FORM 4 wk-form4_1738962616.xml 4 3977
  Complete submission text file 0001790340-25-000024.txt   5434
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNEERING CORPORATION 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address
Zeskind Benjamin J. (Reporting) CIK: 0001870062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40675 | Film No.: 25601813